✦ LIBER ✦

194 The distinctive biology of diffuse large B-cell lymphoma (DLBCL) in adolescents and young adults (AYA)

✍ Scribed by S.V. Semochkin; M.M. Bobkova; V.V. Ptushkin; A.G. Rumyantsev

Book ID: 119601982
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 50 KB
Volume: 8
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(10)71001-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

55 Intensive chemotherapy improves the o

55 Intensive chemotherapy improves the outcome in adolescents and young adults (AYA) with germinal center B-cell-like type diffuse large B-cell lymphoma (DLBCL)

✍ S. Semochkin; M. Bobkova; V. Ivanova; T. Perestoronina; V. Ptushkin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Cytogenetics and fluorescence in situ hy

Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults

✍ Bhavana J. Dave; Dennis D. Weisenburger; Christine M. Higgins; Diane L. Pickerin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Prognostic Factors, Treatment, and Outco

Prognostic Factors, Treatment, and Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab (R) Era

✍ Hiniker, S.M.; Pollom, E.L.; Khodadoust, M.S.; Kozak, M.M.; Advani, R.H.; Hoppe, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Dose-intensified treatment of Burkitt ly

Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): A comparison of two adapted BFM protocols

✍ Sudhir Tauro; Lynda Cochrane; Grete Fossum Lauritzsen; Lee Baker; Jan Delabie; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract The chemotherapy dose‐intensity in two adapted German BFM paediatric protocols (BFM 90 and NHL 86) was compared in contemporaneously treated adults <50 years with Burkitt lymphoma and B‐cell lymphoma unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and Bu

CD30 expression defines a novel subgroup

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

✍ Hu, S.; Xu-Monette, Z. Y.; Balasubramanyam, A.; Manyam, G. C.; Visco, C.; Tzanko 📂 Article 📅 2013 🏛 American Society of Hematology 🌐 English ⚖ 888 KB

N-linked Glycosylation Enrichment for In

N-linked Glycosylation Enrichment for In-depth Cell Surface Proteomics of Diffuse Large B-cell Lymphoma Subtypes

✍ Deeb, S. J.; Cox, J.; Schmidt-Supprian, M.; Mann, M. 📂 Article 📅 2013 🏛 The American Society for Biochemistry and Molecula 🌐 English ⚖ 915 KB